Global CRO advancing clinical research across Phase I–IV drug development, with over 3,500 experts organized into six therapeutic areas from oncology to rare diseases.
Worldwide Clinical Trials is a global Contract Research Organization (CRO) with more than 30 years in operation and a team of over 3,500 clinicians, scientists, and researchers. The firm advances clinical research across all phases of drug development, from Phase I clinical pharmacology through Phase IV trials, delivering customized clinical trial solutions rather than off-the-shelf approaches. Senior-level experts work directly with clients, a model built on personalized attention and deep scientific and operational expertise.
Its clinical teams are organized by therapeutic area - rare diseases, cardiovascular and metabolic conditions, cell and gene therapy, oncology, neuroscience, and immune-mediated inflammatory diseases. This therapeutically aligned structure underpins full-service clinical development spanning clinical trial operations and clinical pharmacology across Phase I–IV, applied to complex programmes in pharmaceuticals and biopharmaceuticals worldwide.
The organisation describes itself as mission-driven, working with purpose to improve lives and to ensure patients benefit from breakthrough therapies. Its stated culture embraces complexity and boundary-pushing innovation, favouring customized solutions, and places scientific knowledge and operational excellence at the centre of its work.
